Institute of Clinical Chemistry and Laboratory Medicine, Jena University Hospital, Friedrich Schiller University Jena, Germany.
Shock. 2011 Dec;36(6):560-9. doi: 10.1097/SHK.0b013e318237ea7c.
Early differential diagnosis of systemic inflammatory reactions in critically ill patients is essential for timely implementation of lifesaving therapies. Despite many efforts made, reliable biomarkers to discriminate between infectious and noninfectious causes of systemic inflammatory response syndrome (SIRS) are currently not available. Recent advances in mass spectrometry-based methods have raised hopes that identification of spectral patterns from serum/plasma samples can be instrumental in this context. We compared protein expression patterns from patients with SIRS of infectious and noninfectious origin. Plasma samples from 166 patients obtained under rigorously standardized preanalytical conditions were applied to Q10 and CM10 ProteinChips. Protein profiles were used to train and develop decision tree classification algorithms. Discriminatory peaks were isolated and identified. Classification trees distinguished patients with noninfectious SIRS with organ dysfunction following open heart surgery using cardiopulmonary bypass from those with severe sepsis or septic shock with distinct sensitivities and specificities. Results were validated in a blinded test set in two independent experiments and in a second independently collected test set. Discriminatory peaks at 13.8 and 55.7 kd were identified as transthyretin and α1-antitrypsin; the third protein at m/z 4,798 was assigned to a proteolytic fragment of α1-antitrypsin. Taken together, our data demonstrate that plasma protein profiling allows reproducible discrimination between patients with infectious and noninfectious SIRS with high sensitivity and specificity. However, rigorous standardization as well as considering drug-related interferences is essential when interpreting protein profiling studies. Identification of discriminatory proteins suggests a direct link between infectious-related protease activity and a sepsis-specific diagnostic pattern for discrimination of patients with SIRS.
早期鉴别危重病患者全身炎症反应的病因对于及时实施救生治疗至关重要。尽管已经做了很多努力,但目前仍缺乏可靠的生物标志物来区分全身炎症反应综合征(SIRS)的感染性和非感染性病因。基于质谱的方法的最新进展带来了希望,即从血清/血浆样本中识别光谱模式可以对此有所帮助。我们比较了感染性和非感染性 SIRS 患者的蛋白质表达模式。在严格标准化的预分析条件下从 166 名患者获得的血浆样本被应用于 Q10 和 CM10 ProteinChips。蛋白质图谱用于训练和开发决策树分类算法。分离和鉴定了有区别的峰。分类树使用心肺旁路术导致的非感染性 SIRS 伴有器官功能障碍的患者与严重脓毒症或感染性休克患者进行了区分,具有不同的敏感性和特异性。结果在两个独立实验的盲测集以及第二个独立收集的测试集中进行了验证。在 13.8 和 55.7 kd 处的鉴别峰被鉴定为转甲状腺素蛋白和α1-抗胰蛋白酶;m/z 4798 处的第三个蛋白质被分配给α1-抗胰蛋白酶的蛋白水解片段。总之,我们的数据表明,血浆蛋白质谱分析可实现对感染性和非感染性 SIRS 患者的可重复性鉴别,具有高灵敏度和特异性。然而,在解释蛋白质谱研究时,严格的标准化以及考虑药物相关干扰是必不可少的。鉴别蛋白的鉴定表明感染相关蛋白酶活性与脓毒症特异性诊断模式之间存在直接联系,可用于区分 SIRS 患者。